NCT06725810View on ClinicalTrials.gov

Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease

PHASE4RecruitingINTERVENTIONAL

Enrollment

1,670

Participants

Timeline

Start Date

March 27, 2025

Primary Completion Date

January 1, 2029

Study Completion Date

February 1, 2029

Conditions

Chronic Kidney Disease Associated Anemia

Interventions

DRUG

Enarodustat

Patients are administered with enarodustat with dosage adjusted according to hemoglobin levels to achieve and maintain hemoglobin target over 96 weeks.

Trial Locations (1)

200043

RECRUITING

Zhongshan hospital, Fudan University, Shanghai

All Listed Sponsors

lead

Shanghai Zhongshan Hospital

OTHER